EPISODE · May 15, 2023 · 42 MIN
Immune-Mediated Thrombocytopenia in a Dog with Dr. Bugbee
from Clinician's Brief: The Podcast · host Brief Media
In this episode, host Alyssa Watson, DVM, talks with Andrew Bugbee, DVM, DACVIM, about his recent Clinician’s Brief article, “Immune-Mediated Thrombocytopenia in a Dog.” To start, Dr. Bugbee explains the differences between primary and secondary cases of ITP, highlighting the platelet “cutoff” for spontaneous bleeding and some of the disease sequelae you may encounter. He then elaborates on therapy and follow-up, with steroids as the primary medication and several drugs that can be considered for secondary use.Resource:https://www.cliniciansbrief.com/article/immune-mediated-thrombocytopenia-dogContact us:[email protected] to find us:Youtube.com/@clinicians_briefCliniciansbrief.com/podcastsFacebook.com/clinciansbriefTwitter: @cliniciansbriefInstagram: @clinicians.briefThe Team:Alyssa Watson, DVM - HostAlexis Ussery - Producer & Multimedia Specialist
What this episode covers
In this episode, host Alyssa Watson, DVM, talks with Andrew Bugbee, DVM, DACVIM, about his recent Clinician’s Brief article, “Immune-Mediated Thrombocytopenia in a Dog.” To start, Dr. Bugbee explains the differences between primary and secondary cases of ITP, highlighting the platelet “cutoff” for spontaneous bleeding and some of the disease sequelae you may encounter. He then elaborates on therapy and follow-up, with steroids as the primary medication and several drugs that can be considered for secondary use. Resource: https://www.cliniciansbrief.com/article/immune-mediated-thrombocytopenia-dog Contact us: [email protected] Where to find us: Youtube.com/@clinicians_brief Cliniciansbrief.com/podcasts Facebook.com/clinciansbrief Twitter: @cliniciansbrief Instagram: @clinicians.brief The Team: Alyssa Watson, DVM - Host Alexis Ussery - Producer & Multimedia Specialist
NOW PLAYING
Immune-Mediated Thrombocytopenia in a Dog with Dr. Bugbee
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m